Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Konkret geht es um den Diabetes-Patienten mit kardiovaskulären Erkrankungen oder Risiken, die Herzinsuffizienz sowie die kardiovaskuläre Primär- und Sekundärprävention. Sind Sie hier schon auf dem neuesten Stand? Unsere Experten beleuchten, wo und warum das bisherige Procedere geändert werden soll und was in der Praxis sinnvoll ist. Holen Sie sich Ihr Update und 2 CME-Punkte beim MMW-Webinar am 24. April von 17.30 bis 19 Uhr. 
Erweiterte Suche
Anmelden
nach oben
International Journal of Diabetes in Developing Countries
Erschienen in: International Journal of Diabetes in Developing Countries 2/2017

27.05.2017 | Editorial

Diabetes mellitus and tuberculosis—a double whammy

verfasst von: S. V. Madhu

Erschienen in: International Journal of Diabetes in Developing Countries | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Excerpt

India has the second highest prevalence of diabetes mellitus in the world with over 69.2 million diabetes subjects [1]. So also, India accounts for a significant proportion of cases of tuberculosis in the world. It is also estimated that the highest number of cases of tuberculosis associated with diabetes are reported from India and a large proportion of diabetic patients in our country suffer from tuberculosis [2‐4]. This suggests a huge double burden of diabetes and tuberculosis in our country. …
Literatur
1.
IDF diabetes atlas. 7th Edition. Brussels: International Diabetes Federation; 2015.
2.
Harries AD, Satyanarayana S, Kumar AM, et al. Epidemiology and interaction of diabetes mellitus and tuberculosis and challenges for care: a review. Public Health Action. 2013;3(Suppl 1):S3–9.CrossRefPubMedPubMedCentral
3.
Lonnroth K, Roglic G, Harries AD. Improving tuberculosis prevention and care through addressing the global diabetes epidemic: from evidence to policy and practice. Lancet Diabetes Endocrinol. 2014;2(9):730–9.CrossRefPubMed
4.
Zheng C, Hu M, Gao F. Diabetes and pulmonary tuberculosis: a global overview with special focus on the situation in Asian countries with high TB-DM burden. Glob Health Action. 2017;10(1):1–11.PubMed
5.
Singh SP, Singh SP, Kishan J, Kaur S, Ramana S. Association of tuberculosis and diabetes mellitus: an analysis of 1000 consecutively admitted cases in a tertiary care hospital of North India. Pan Afr Med J. 2016;24:4.CrossRefPubMedPubMedCentral
6.
Balakrishnan S, Vijayan S, Nair S, et al. High diabetes prevalence among tuberculosis cases in Kerala, India. PLoS ONE. 2012;7(10):e46502.
7.
Viswanathan V, Kumpatla S, Aravindalochanan V, et al. Prevalence of diabetes and pre-diabetes and associated risk factors among tuberculosis patients in India. PLoS One. 2012;7(7):e41367.CrossRefPubMedPubMedCentral
8.
Raghuraman S, Vasudevan KP, Govindarajan S, Chinnakali P, Panigrahi KC. Prevalence of diabetes mellitus among tuberculosis patients in urban Puducherry. N Am J Med Sci. 2014;Vol 6:30–4.CrossRef
9.
Anjana RM, Pradeepa R, Deepa M, Datta M, Sudha V, Unnikrishnan R, Bhansali A, Joshi SR, Joshi PP, Yajnik CS, Dhandhania VK, Nath LM, Das AK, Rao PV, Madhu SV, Shukla DK, Kaur T, Priya M, Nirmal E, Parvathi SJ, Subhashini S, Subashini R, Ali MK, Mohan V, ICMR–INDIAB Collaborative Study Group. Prevalence of diabetes and prediabetes (impaired fasting glucose and/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR-INDIAB) study. Diabetologia. 2011;54:3022–7.CrossRefPubMed
10.
Hodgson K, Morris J, Bridson T, Govan B, Rush C, Ketheesan N. Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections. Immunology. 2015;144(2):171–85.CrossRefPubMedPubMedCentral
11.
Perez-Navarro LM, Restrepo BI, Fuentes-Dominguez FJ, et al. The effect size of type 2 diabetes mellitus on tuberculosis drug resistance and adverse treatment outcomes. Tuberculosis (Edinb). 2017;103:83–91.CrossRef
12.
Restrepo BI, Fisher-Hoch SP, Smith B, et al. Mycobacterial clearance from sputum is delayed during the first phase of treatment in patients with diabetes. AmJTrop Med Hyg. 2008;79(4):541–4.
Metadaten
Titel
Diabetes mellitus and tuberculosis—a double whammy
verfasst von
S. V. Madhu
Publikationsdatum
27.05.2017
Verlag
Springer India
Erschienen in
International Journal of Diabetes in Developing Countries / Ausgabe 2/2017
Print ISSN: 0973-3930
Elektronische ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-017-0562-5

Weitere Artikel der Ausgabe 2/2017

International Journal of Diabetes in Developing Countries 2/2017 Zur Ausgabe

Original Article

Association between single nucleotide polymorphisms (SNPs) in the gene of ADP-ribosylation factor-like 15 (ARL15) and type 2 diabetes (T2D) in Korean Chinese population in Yanbian, China

Original Article

Importance of anthropometry in assessing insulin resistance as a pre-alarming sign before the onset of metabolic syndrome: a study among apparently healthy subjects

Original Article

Targeting inflammation using celecoxib with glimepiride in the treatment of obese type 2 diabetic Egyptian patients

Original Article

Effect of reward-based motivation on metabolic control in children and adolescents with type 1 diabetes mellitus

Original Article

Effect of square aerobic exercise on cardiovascular risk factors and health-related quality of life in Chinese women with type 2 diabetes

Original Article

Insulin lispro low mixture twice daily versus basal insulin glargine once daily and prandial insulin lispro once daily in patients with type 2 diabetes mellitus requiring insulin intensification—a randomized phase IV trial: Indian subpopulation analyses